• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与式医疗保健决策中的代表性:对应用型模型的反思。

Representation in participatory health care decision-making: Reflections on an Application-Oriented Model.

机构信息

Institute of Social Medicine and Epidemiology, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany.

Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Potsdam, Germany.

出版信息

Health Expect. 2022 Aug;25(4):1444-1452. doi: 10.1111/hex.13483. Epub 2022 Mar 27.

DOI:10.1111/hex.13483
PMID:35340091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9327827/
Abstract

CONTEXT

The involvement of lay people in health care decision-making processes is now the norm in many countries. However, one important aspect of participation has not received sufficient attention in the past and remains underexplored: representation.

OBJECTIVE

This paper explores the question of how public participation efforts in collective health care decision-making processes can attempt to aim for legitimate representation so that those individuals or groups not present can be taken into account in the decisions affecting them. This paper argues that to make decisions that effectively address those affected, representation needs to be seen as a relevant part of any participatory setting. To support this argument, the paper outlines the concepts of participation and representation and transfers them to health care contexts.

RESULTS

A conceptual reflection on responsiveness and the characteristics of representative actors in representative-participatory settings is introduced, which could provide actors planning to conduct participatory health care projects with tools to reflect on the merits and possible flaws of participatory constellations.

PATIENT OR PUBLIC CONTRIBUTION

The paper contributes to improving public participation in health care decision-making.

摘要

背景

在许多国家,现在非专业人士参与医疗决策过程已成为常态。然而,参与的一个重要方面在过去没有得到足够的重视,仍未得到充分探索:代表性。

目的

本文探讨了在集体医疗保健决策过程中的公众参与努力如何试图争取合法的代表性,以便将那些未出席的个人或群体纳入影响他们的决策中。本文认为,为了做出能够有效解决受影响者问题的决策,代表性需要被视为任何参与性设置的一个相关部分。为了支持这一论点,本文概述了参与和代表性的概念,并将其转化为医疗保健背景。

结果

本文引入了对回应性和代表性参与性设置中代表性行为者特征的概念性反思,这可为计划进行参与式医疗保健项目的行为者提供工具,以反思参与性组合的优点和可能的缺陷。

患者或公众的贡献

本文有助于改善医疗保健决策中的公众参与。

相似文献

1
Representation in participatory health care decision-making: Reflections on an Application-Oriented Model.参与式医疗保健决策中的代表性:对应用型模型的反思。
Health Expect. 2022 Aug;25(4):1444-1452. doi: 10.1111/hex.13483. Epub 2022 Mar 27.
2
[How to build the legitimacy of patient and consumer participation in health issues?].如何建立患者和消费者在健康问题上参与的合法性?
Sante Publique. 2006 Jun;18(2):171-86. doi: 10.3917/spub.062.0171.
3
Representative Claims in Healthcare: Identifying the Variety in Patient Representation.医疗保健中的代表性主张:识别患者代表性的多样性。
J Bioeth Inq. 2018 Sep;15(3):359-368. doi: 10.1007/s11673-018-9861-x. Epub 2018 Jun 7.
4
Introduction: priority setting, equitable access and public involvement in health care.引言:卫生保健中的优先事项设定、公平获取与公众参与
J Health Organ Manag. 2016 Aug 15;30(5):736-50. doi: 10.1108/JHOM-03-2016-0036.
5
Nepal's Health Facility Operation and Management Committees: exploring community participation and influence in the Dang district's primary care clinics.尼泊尔的卫生设施运营与管理委员会:探索当地区初级保健诊所中的社区参与及影响
Prim Health Care Res Dev. 2018 Sep;19(5):492-502. doi: 10.1017/S1463423618000026. Epub 2018 Jan 28.
6
Lay participation in health care decision making: a conceptual framework.非专业人士参与医疗保健决策:一个概念框架。
J Health Polit Policy Law. 1993 Winter;18(4):881-904. doi: 10.1215/03616878-18-4-881.
7
Whose voices? Patient and public involvement in clinical commissioning.谁的声音?患者及公众参与临床委托服务
Health Expect. 2017 Jun;20(3):484-494. doi: 10.1111/hex.12475. Epub 2016 Jun 29.
8
Patterns of public participation.公众参与模式
J Health Organ Manag. 2016 Aug 15;30(5):751-68. doi: 10.1108/JHOM-03-2016-0037.
9
Public participation in decision-making on the coverage of new antivirals for hepatitis C.公众参与丙型肝炎新型抗病毒药物覆盖范围的决策。
J Health Organ Manag. 2016 Aug 15;30(5):769-85. doi: 10.1108/JHOM-03-2016-0035.
10
[Collective participation and the elicitation of preferences for health care programs: a health system perspective].[集体参与与医疗保健项目偏好的引出:卫生系统视角]
Gac Sanit. 2005 May-Jun;19(3):242-52. doi: 10.1157/13075959.

引用本文的文献

1
The role of representation in participatory settings of health research in Germany: protocol for a scoping review.代表性在德国健康研究参与式环境中的作用:一项范围综述方案
Res Involv Engagem. 2025 Jul 3;11(1):75. doi: 10.1186/s40900-025-00736-w.
2
[Representation and representativeness in health councils: between formalization and participatory legitimacy].[卫生委员会中的代表性与代表性:在形式化与参与性合法性之间]
Cad Saude Publica. 2025 Feb 7;40(12):e00115524. doi: 10.1590/0102-311XPT115524. eCollection 2025.
3
Establishing a standing patient advisory board in family practice research: A qualitative evaluation from patients' and researchers' perspectives.在家庭医学研究中设立常设患者顾问委员会:来自患者和研究人员视角的定性评估。
Health Expect. 2024 Jun;27(3):e14094. doi: 10.1111/hex.14094.
4
Representation in participatory healthcare decision-making.参与性医疗决策中的代表性。
Health Expect. 2022 Aug;25(4):1190-1191. doi: 10.1111/hex.13521. Epub 2022 May 8.

本文引用的文献

1
Exploring the theory, barriers and enablers for patient and public involvement across health, social care and patient safety: a systematic review of reviews.探索患者和公众参与健康、社会关怀和患者安全的理论、障碍和促进因素:系统综述。
Health Res Policy Syst. 2021 Jan 20;19(1):8. doi: 10.1186/s12961-020-00644-3.
2
Public and patient participation in health policy, care and research.公众和患者参与卫生政策、医疗保健及研究。
Porto Biomed J. 2017 Mar-Apr;2(2):31-32. doi: 10.1016/j.pbj.2017.01.001. Epub 2017 Mar 1.
3
Ethical Advocacy Across the Autism Spectrum: Beyond Partial Representation.自闭症谱系中的伦理倡导:超越片面代表。
Am J Bioeth. 2020 May;20(4):13-24. doi: 10.1080/15265161.2020.1730482.
4
A history of antipsychiatry in four books.四本书中的反精神病学历史。
Lancet Psychiatry. 2020 Apr;7(4):312-314. doi: 10.1016/S2215-0366(20)30106-1.
5
[Is there a need for more patient participation in Germany? : Analysis and outlook].[德国是否需要更多患者参与?:分析与展望]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Sep;62(9):1113-1119. doi: 10.1007/s00103-019-02994-y.
6
Patient organizations and conflict of interest.
BMJ. 2019 Jan 16;364:l129. doi: 10.1136/bmj.l129.
7
The challenge of democratic patient representation: Understanding the representation work of patient organizations through methodological triangulation.民主的患者代表面临的挑战:通过方法学的三角测量理解患者组织的代表性工作。
Health Policy. 2019 Jan;123(1):109-114. doi: 10.1016/j.healthpol.2018.11.011. Epub 2018 Nov 27.
8
Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis.患者和公众参与对临床试验入组和保留的影响:系统评价和荟萃分析。
BMJ. 2018 Nov 28;363:k4738. doi: 10.1136/bmj.k4738.
9
Patient and public engagement in research and health system decision making: A systematic review of evaluation tools.患者和公众参与研究和卫生系统决策:评价工具的系统评价。
Health Expect. 2018 Dec;21(6):1075-1084. doi: 10.1111/hex.12804. Epub 2018 Jul 30.
10
Legislating Patient Representation: A Comparison Between Austrian and German Regulations on Self-Help Organizations as Patient Representatives.为患者代表立法:奥地利与德国关于自助组织作为患者代表的法规比较
J Bioeth Inq. 2018 Sep;15(3):351-358. doi: 10.1007/s11673-018-9864-7. Epub 2018 Jul 2.